Literature DB >> 1470957

Disseminated histoplasmosis in patients with AIDS.

M A Neubauer1, D C Bodensteiner.   

Abstract

Disseminated histoplasmosis (DH) is recognized as an opportunistic infection in patients with the human immunodeficiency virus (HIV), especially in regions where histoplasmosis is endemic. At the Kansas University Medical Center 148 patients were hospitalized with the diagnosis of AIDS from December 1983 to March 1991; 23 of these patients (16%) had disseminated histoplasmosis. The charts of these 23 patients were reviewed. Clinical signs and symptoms included fever (91%), cough (65%), and weight loss (48%). Splenomegaly, hepatomegaly, or lymphadenopathy was present in 52% of all patients. Anemia (39%), leukopenia (65%), and thrombocytopenia (52%) were common, and 22% had pancytopenia. Diagnosis was made by peripheral smear examinations (organisms visualized on 7 of 22 smears [32%]), blood cultures (positive for H capsulatum in 16 of 20 patients, [80%]), bone marrow cultures (positive in 14 of 15 patients, [93%]), and bone marrow aspirate and biopsy examinations (organisms seen on 18 of 21 stains, [86%]). The combination of these four tests revealed the diagnosis of DH in 23 of 23 patients (100%). Induction and maintenance amphotericin B therapy was given to all but 2 patients, and currently 8 of the 23 are alive. DH is a common opportunistic infection in AIDS patients from regions endemic for histoplasmosis. When DH is suspected, a peripheral smear examination, blood cultures, bone marrow cultures and bone marrow aspirate and biopsy should be done to make the diagnosis, since suppression of the disease is possible with appropriate therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1470957     DOI: 10.1097/00007611-199212000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  Aetiological study of the presumed ocular histoplasmosis syndrome in the Netherlands.

Authors:  J V Ongkosuwito; L M Kortbeek; A Van der Lelij; E Molicka; A Kijlstra; M D de Smet; M S Suttorp-Schulten
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

2.  Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum.

Authors:  S L Newman; L Gootee; J E Gabay; M E Selsted
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Molecular detection of Histoplasma capsulatum var. capsulatum in human clinical samples.

Authors:  Andrea Bracca; María Elena Tosello; Javier E Girardini; Susana L Amigot; Carlos Gomez; Esteban Serra
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120.

Authors:  S Chaturvedi; S L Newman
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Disseminated histoplasmosis in patients with acquired immunodeficiency syndrome.

Authors:  R F Miller; S B Lucas; A J Pinching
Journal:  Genitourin Med       Date:  1994-04

Review 6.  Endemic mycoses in AIDS: a clinical review.

Authors:  J Wheat
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Treating progressive disseminated histoplasmosis in people living with HIV.

Authors:  Marylou Murray; Paul Hine
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.